Inspirive Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Revenue %
(FY 2020)
- Profit -164.27%
(FY 2020)
- Ebitda -233.57%
(FY 2020)
- Net Worth -19.10%
(FY 2020)
- Total Assets 44.81%
(FY 2020)
About Inspirive Pharmaceuticals
The Corporate was formerly known as Umby Lifesciences Private Limited. The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohd Rais, Raj Rastogi, Rajendra Banerjee, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304UP2018PTC107311
- Company No.
107311
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Inspirive Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohd Rais  | Director | 30-Aug-2018 | Current |
| Raj Rastogi | Director | 30-Aug-2018 | Current |
| Rajendra Banerjee | Director | 30-Aug-2018 | Current |
| Anuj Rastogi | Director | 30-Oct-2018 | Current |
Financial Performance of Inspirive Pharmaceuticals.
Inspirive Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 164.27% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inspirive Pharmaceuticals?
Unlock access to Inspirive Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Inspirive Pharmaceuticals?
Unlock and access historical data on people associated with Inspirive Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inspirive Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inspirive Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
